Sarcopenia does not predict outcome in patients with CNS lymphoma undergoing systemic therapy

Low skeletal muscle mass as a proxy parameter for sarcopenia acts as a non-invasive imaging marker that is associated with poor prognosis in numerous types of cancer. The present study aimed to assess the influence of body composition parameters on overall survival (OS) and progression free survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraro, Vincenzo, Thormann, Maximilian, Hinnerichs, Mattes, Pech, Maciej, Wolleschak, Denise, Mougiakakos, Dimitrios, Wienke, Andreas, Strobel, Alexandra, Zeremski, Vanja, Surov, Alexey, Omari, Jazan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478615/
https://www.ncbi.nlm.nih.gov/pubmed/36168307
http://dx.doi.org/10.3892/ol.2022.13475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478615/
https://www.ncbi.nlm.nih.gov/pubmed/36168307
http://dx.doi.org/10.3892/ol.2022.13475

Ejemplares similares